China Tian Yuan Healthcare Group (HKSE:00557) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00557 China Tian Yuan Healthcare Group Ltd HKSE:00557
28 GF Score
Price HK$0.55
GF Value HK$0.32
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is China Tian Yuan Healthcare Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

China Tian Yuan Healthcare Group Valuation Rank Related Terms

HKSE:00557
28GF Score
China Tian Yuan Healthcare Group Ltd HKSE:00557
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China Tian Yuan Healthcare Group (HKSE:00557) Overvalued in 2026?

Based on GuruFocus' analysis, China Tian Yuan Healthcare Group stock appears to be overvalued. The current stock price of HK$0.55 is trading 70.3% above its estimated GF Value™ of HK$0.32. GuruFocus considers China Tian Yuan Healthcare Group to be Significantly Overvalued.

Key valuation signals for HKSE:00557:

  • Valuation Rank:
  • GF Value™: HK$0.32 vs. price of HK$0.55 (70.3% above fair value)
  • GF Score™: 28/100 with 5 warning signs

No single metric tells the full story. See the HKSE:00557 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Tian Yuan Healthcare Group Business Description

Address 80 Gloucester Road, 11th Floor, Wanchai, Hong Kong, HKG
China Tian Yuan Healthcare Group Ltd is an investment holding company engaged in investment holding, provision of procurement, marketing and management services to the medical industry, provision of procurement services relating to the hospitality industry, licensing of trademarks, and money lending and related business. Its segments include Investment Holding, Healthcare, Money Lending and Related Business, which generates maximum revenue from interests earned from the provision of loans to third parties, referral and handling fees for loan-related services, and the introduction of prospective lenders and borrowers in PRC and Hong Kong; and Hospitality. The company generates maximum revenue from Hong Kong.
28GF Score

Get the complete analysis for HKSE:00557

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.55
Price
HK$0.32
GF Value